Literature DB >> 16189809

A new approach to sample size calculation for reference interval studies.

C Jennen-Steinmetz1, S Wellek.   

Abstract

A new criterion is proposed for determining the sample size required for a study performed for the purpose of establishing reference intervals. The basic idea behind the criterion is to compare the empirical coverage (i.e. the probability content) of the reference region obtained from the sample with its target value (e.g. 95 per cent) and to set suitable limits delta1, delta2 to the difference between both quantities which must not be exceeded with sufficiently large probability beta (e.g. beta=90 per cent). For the most frequently used parametric and distribution-free methods of estimating univariate reference limits, implicit formulae are derived relating the sample size to the design parameters delta1, delta2 and beta. For symmetric specification of (delta1, delta2), explicit approximation formulae for the computation of n are given. Exact values obtained by means of suitable numerical techniques are presented in a set of tables covering specifications of delta1, delta2 and beta which can be recommended for real applications. The tables can be used both for one- and two-sided reference intervals. 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16189809     DOI: 10.1002/sim.2177

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  9 in total

1.  Evolution of C-reactive protein values in the first month after anterior cruciate ligament reconstruction: reference values.

Authors:  Miguel A Ruiz-Ibán; Jorge Díaz Heredia; Ignacio Cebreiro Martínez Val; Susana Alonso Güemes; Ricardo Cuéllar Gutiérrez; Sergi Sastre Solsona
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-10-11       Impact factor: 4.342

2.  Prevalence of sarcopenia in healthy community-dwelling elderly in an urban area of Barcelona (Spain).

Authors:  F Masanes; A Culla; M Navarro-Gonzalez; M Navarro-Lopez; E Sacanella; B Torres; A Lopez-Soto
Journal:  J Nutr Health Aging       Date:  2012-02       Impact factor: 4.075

Review 3.  Autoantibodies in Rheumatoid Arthritis - Laboratory and Clinical Perspectives.

Authors:  Johan Rönnelid; Carl Turesson; Alf Kastbom
Journal:  Front Immunol       Date:  2021-05-14       Impact factor: 7.561

Review 4.  Importance of health assessments for conservation in noncaptive wildlife.

Authors:  Sara Kophamel; Björn Illing; Ellen Ariel; Morgan Difalco; Lee F Skerratt; Mark Hamann; Leigh C Ward; Diana Méndez; Suzanne L Munns
Journal:  Conserv Biol       Date:  2021-05-11       Impact factor: 7.563

5.  The Montreal Cognitive Assessment: Normative Data from a German-Speaking Cohort and Comparison with International Normative Samples.

Authors:  Alessandra E Thomann; Nicolai Goettel; Raphael J Monsch; Manfred Berres; Thomas Jahn; Luzius A Steiner; Andreas U Monsch
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

6.  Cerebral Oxygen Changes in Neonates During Immediate Transition After Birth and Early Life: An Observational Study.

Authors:  Hang Xue; Ziyi Wu; Jiaxin Yao; Anqi Zhao; Lanlan Zheng; Xiao Yin; Fang Wang; Ping Zhao
Journal:  Drug Des Devel Ther       Date:  2020-11-02       Impact factor: 4.162

7.  Normal reference intervals of prognostic nutritional index in healthy adults: A large multi-center observational study from Western China.

Authors:  Guishu Yang; Dongsheng Wang; Linbo He; Guangjie Zhang; Jianhong Yu; Yaping Chen; Hailin Yin; Tian Li; Ying Lin; Huaichao Luo
Journal:  J Clin Lab Anal       Date:  2021-05-21       Impact factor: 2.352

8.  Biometry reference range of the corpus callosum in neonates: An observational study.

Authors:  Yanyan Gao; Kai Yan; Lin Yang; Guoqiang Cheng; Wenhao Zhou
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

9.  Reference range: Which statistical intervals to use?

Authors:  Wei Liu; Frank Bretz; Mario Cortina-Borja
Journal:  Stat Methods Med Res       Date:  2020-10-14       Impact factor: 3.021

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.